JAZZ PHARMACEUTICALS SOBRE LOS RIESGOS E INCERTIDUMBRES CON LURBINECTEDIN ( ZEPZELCA ) ... : PREVEMOS QUE LURBINECTEDIN ( ZEPZELCA ) COMPITA CON PRODUCTOS GENÉRICOS EN EL FUTURO .
Scientists have crafted an experimental vaccine against advanced ovarian cancer that was safe and triggered an immune response using muscled-up blood cells primed by tumors that were taken from the patients.